Life science News and Research

RSS

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

Bio-Rad announces release of beta version of the USP Spectral Library

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the release of beta version of USP Spectral Library™ powered by Bio Rad's KnowItAll® software technology platform for spectral analysis, identification, search, data management, and reporting.

From Bio-Rad Laboratories 5 Mar 2014

Right time for NCKU to jump into cryo-electron microscopy

"Now is really the perfect time in history for the university here in Tainan to jump into the field of cryo-EM (cryo-electron microscopy)," said Dr. Robert M. Glaeser, Professor Emeritus of Biochemistry, Biophysics and Structural Biology, UC Berkeley, USA, at a symposium held at National Cheng Kung University (NCKU), Tainan, Taiwan, March 4th.

5 Mar 2014

Oxford Gene Technology announces acquisition of Cytocell

Oxford Gene Technology, a provider of innovative genetics research solutions, today announced the acquisition of Cambridge-based Cytocell Limited, a leading provider of DNA technology for the detection of gene rearrangements related to inherited genetic disease and cancer.

From Oxford Gene Technology 4 Mar 2014

ASN to conduct Scientific Sessions and Annual Meeting at Experimental Biology in San Diego

The American Society for Nutrition (ASN) will hold its 2014 Scientific Sessions and Annual Meeting at Experimental Biology (EB), from April 26-30, 2014, in San Diego. EB 2014 brings together the leading researchers from dozens of life-science disciplines.

3 Mar 2014

Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma

Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.

28 Feb 2014

Agilent and CambTEK partner to co-market RES automated sample preparation technology

Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK's Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent's liquid phase separation, life science and chemical analysis instruments and software.

26 Feb 2014

Combining Nanophotonics and Microfluidics for the Characterization of Nanoparticles

In this interview, Bernardo Cordovez describes the development of a new nanophotonic chip that can be used to characterize nanoparticles.

From Halo Labs 24 Feb 2014

Biochrom launches EZ Nin Reagent for use in ion exchange chromatography systems

Biochrom Ltd, a manufacturer of quality scientific instruments for applications in the life science, clinical, and analytical markets, announced today the commercial launch of its EZ Nin ReagentTM, a ready-to-use ninhydrin formulation for use in ion exchange chromatography systems with post-column derivatisation for improved amino acid analysis.

From Biochrom Ltd. 24 Feb 2014

Wellcome Trust to launch new digital publication dedicated to science of life

Mosaic, a new digital publication dedicated to exploring the science of life, is set to launch on 4 March 2014. Mosaic will carry long-form features, articles and films that tell the stories behind biomedical research and its impact on society.

20 Feb 2014

Bioline enters Epigenetics field with launch of new EPIK product range

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., announces that it has entered the rapidly growing Epigenetics field, with the launch of the first kits in the new EPIK™ product range; EPIK™ Fast Quantification Kit and EPIK™ Amplification Kit.

18 Feb 2014

Novimmune closes Series B financing for CHF 60 million

Novimmune SA announced that it has closed a Series B financing for CHF 60 million ($66 million). London-based Rosetta Capital Limited led the round with participation of new private investors as well as existing investors.

18 Feb 2014

UMMS launches Voyager Therapeutics to develop life-changing treatments for fatal diseases

UMass Medical School (UMMS) recognizes the launch today of Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, to develop life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).

13 Feb 2014

$Sage Science releases new SageELF technology for DNA and protein fractionation$

Sage Science releases new SageELF technology for DNA and protein fractionation

Sage Science, a developer of products for improving sample preparation processes in life science applications, today announced the release of its new SageELF technology for DNA and protein fractionation. This sample prep instrument will be especially useful for preserving precious samples and has applications in next-generation sequencing as well as bottom-up or top-down proteomics experiments.

12 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Porvair Sciences to showcase specialist microplate products at Pittcon, Analytica and Genomics Research 2014

Porvair Sciences has announced that it will be showing its latest specialist microplates and microplate equipment at the forthcoming Pittcon 2014 (Chicago), Analytica 2014 (Munich) and Genomics Research 2014 (San Francisco) exhibitions.

From Chromatrap® - Porvair Sciences Ltd 11 Feb 2014

Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Psoriasis is the most common autoimmune disease in the US, affecting 2 to 3% of all Americans. What causes psoriasis in any one individual will stem from a mixture of their genetic background and their environment.

4 Feb 2014

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris.

22 Jan 2014

Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

Sigma-Aldrich Corporation, a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics.

21 Jan 2014

PLSG reaches significant landmark in direct investments into life sciences companies

Pittsburgh Life Sciences Greenhouse, the region's only pure life sciences investment firm, and managing member of the PLSG Accelerator Fund, announced today it has made a $65,000 investment into Cohera Medical, Inc. which launches the organization into a $20 million milestone in total investments since the company's inception in 2001.